677.00 -3.40 (-0.50%)
36,644 NSE+BSE Volume
BSEJun 24, 2021 04:00 PM
The 1 reports from 1 analysts offering long term price targets for Amrutanjan Health Care Ltd. have an average target of 670.00. The consensus estimate represents a downside of -1.03% from the last price of 677.00.
|Summary||Date||Stock||Broker||Price at Reco.||Target||Price at reco|
Change since reco(%)
|2021-04-01||Amrutanjan Health Ca.. +||Ashika Research||575.70||670.00||575.70 (17.60%)||Target met||Buy|
apart from other range of pain management products (aromatic balms and roll-ons for headaches, creams and roll-ons for body aches, joint/ muscle sprays), for congestion relief...
|2016-02-05||Amrutanjan Health Ca.. +||Karvy||412.20||504.00||412.20 (64.24%)||Target met||Buy|
Aptly Timed Product Replacement: At the beginning of a slack in its flagship product-yellow balm, Amrutanjan has introduced new formats to replace the same,roll on for convenience in body and head ache and strong neutral coloured balm for headache. The awareness and a rush of larger players in the body ache, aid Amrutanjan in rapid expansion of the segment.
|2015-02-02||Amrutanjan Health Ca.. +||Ashika Research||464.25||650.00||464.25 (45.83%)||Target met||Buy|